David Young

CIK 1378166 · Pres. Research & Development · last filed 2026-06-01

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$38.1K

Companies

3

Total Filings

63

Lifetime Open-Market Net

-$14.49M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PCSA Pres. Research & Development 17,563 $2.17 $38.1K $373.0K 37 2026-06-01
QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted Chief Scientific Officer 122,366 -$14.87M 21 2014-03-18
QUESTCOR PHARMACEUTICALS INC (QSC) Delisted Director $0 4 2008-01-03

Recent Filings · Page 3 of 7

63 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-04-13 PCSA Buy (P) +60,000 $29.0K EDGAR
2023-02-10 PCSA Grant (A) +18,750 $15.0K EDGAR
2023-01-04 PCSA Grant (A) $0 EDGAR
2022-10-03 PCSA Grant (A) $0 EDGAR
2022-08-23 PCSA Gift (G) −9,250 $0 EDGAR
2022-08-09 PCSA Mixed +5,070 -$8.0K EDGAR
2022-07-05 PCSA Grant (A) $0 EDGAR
2022-04-11 PCSA Grant (A) $0 EDGAR
2022-04-04 PCSA Grant (A) $0 EDGAR
2022-01-06 PCSA Grant (A) $0 EDGAR
Showing 2130 of 63
Page 3 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.